Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

TJ Barber, L Harrison, D Asboe… - Journal of …, 2012 - academic.oup.com
Background Selection of protease mutations on antiretroviral therapy (ART) including a
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …
被引用次数：36 相关文章

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

TJ Barber, L Harrison, D Asboe… - The Journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Selection of protease mutations on antiretroviral therapy (ART) including a
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …
[PDF] academia.edu

[PDF][PDF] Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

TJ Barber, L Harrison, D Asboe, I Williams, S Kirk… - 2012 - academia.edu
Background: Selection of protease mutations on antiretroviral therapy (ART) including a
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.

TJ Barber, L Harrison, D Asboe, I Williams… - The Journal of …, 2012 - europepmc.org
Background Selection of protease mutations on antiretroviral therapy (ART) including a
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.

TJ Barber, L Harrison, D Asboe… - Journal of …, 2012 - search.ebscohost.com
Background Selection of protease mutations on antiretroviral therapy (ART) including a
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

TJ Barber, L Harrison, D Asboe… - Journal of …, 2012 - researchportal.ukhsa.gov.uk
Background: Selection of protease mutations on antiretroviral therapy (ART) including a
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

TJ Barber, L Harrison, D Asboe, I Williams… - The Journal of …, 2012 - kclpure.kcl.ac.uk
Background Selection of protease mutations on antiretroviral therapy (ART) including a
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.

TJ Barber, L Harrison, D Asboe, I Williams, S Kirk… - 2012 - cabidigitallibrary.org
Background: Selection of protease mutations on antiretroviral therapy (ART) including a
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …

[引用][C] Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

TJ BARBER, L HARRISON, D ASBOE… - Journal of …, 2012 - pascal-francis.inist.fr
Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with
lopinavir/ritonavir as their first protease inhibitor CNRS Inist Pascal-Francis CNRS Pascal and …

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

TJ Barber, L Harrison, D Asboe… - Journal of …, 2012 - researchonline.gcu.ac.uk
Background: Selection of protease mutations on antiretroviral therapy (ART) including a
ritonavir-boosted protease inhibitor (PI) has been reported infrequently. Scarce data exist …